(4-Benzyl-piperidin-1-yl)-acetic acid → HCID 18002785, 화합물
반응식
Cl.NCC([C:6]1[CH:14]=[C:13]2[C:9]([CH2:10][C:11](=[O:15])[NH:12]2)=[CH:8][CH:7]=1)=O.[CH2:16]([CH:23]1[CH2:28][CH2:27][N:26]([CH2:29][C:30]([OH:32])=O)[CH2:25][CH2:24]1)[C:17]1[CH:22]=[CH:21][CH:20]=[CH:19][CH:18]=1>>[CH2:16]([CH:23]1[CH2:24][CH2:25][N:26]([CH2:29][C:30]([NH:26][CH2:29][C:30](=[O:32])[C:7]2[CH:8]=[C:9]3[C:13](=[CH:14][CH:6]=2)[NH:12][C:11](=[O:15])[CH2:10]3)=[O:32])[CH2:27][CH2:28]1)[C:17]1[CH:18]=[CH:19][CH:20]=[CH:21][CH:22]=1참가 물질
3
실험 절차
Condensation of 6-(2-aminoethanoyl)-1,3-dihydroindol-2-one hydrochloride with (4-benzylpiperidin-1-yl)acetic acid, following the procedure described in Example 6, Step 6, gave 2-(4-benzyl-piperidin-1-yl)-N-[2-oxo-2-(2-oxo-2,3-dihydro-1H-indol-5-yl)ethyl]acetamide:
출처 및 근거
- ORD 기록
- ord-c13dfe6a3b40406796a1ecfef3970c42
- 출처 데이터셋
- uspto-grants-2003_11
- 특허 번호
- US06642256B2
반응 노트
불러오는 중…